Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers

We began analyzing https://link.springer.com/article/10.1007/s10549-012-2226-y, but it redirected us to https://link.springer.com/article/10.1007/s10549-012-2226-y. The analysis below is for the second page.

Title[redir]:
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors | Breast Cancer Research and Treatment
Description:
Though xenografts are used extensively for drug development in breast cancer, how well xenografts reflect the breadth of primary breast tumor subtypes has not been well characterized. Moreover, few studies have compared the gene expression of xenograft tumors to the primary tumors from which they were derived. Here we investigate whether the ability of human breast tumors (n = 20) to create xenografts in immune-deficient mice is associated with breast cancer immunohistochemical (IHC) and intrinsic subtype. We also characterize how precisely the gene expression of xenografts reprises that of parent breast tumors, using hierarchical clustering and other correlation-based techniques applied to Agilent 44K gene expression data from 16 samples including four matched primary tumor-xenograft pairs. Of the breast tumors studied, 25 % (5/20) generated xenografts. Receptor and intrinsic subtype were significant predictors of xenograft success, with all (4/4) triple-negative (TN) tumors and no (0/12) HR+Her2− tumors forming xenografts (P = 0.0005). Tumor cell expression of ALDH1, a stem cell marker, trended toward successful engraftment (P = 0.14), though CDK5/6, a basal marker, did not. Though hierarchical clustering across the 500 most variable genes segregated human breast tumors from xenograft tumors, when clustering was performed over the PAM50 gene set the primary tumor-xenograft pairs clustered together, with all IHC subtypes clustered in distinct groups. Greater similarity between primary tumor-xenograft pairs relative to random pairings was confirmed by calculation of the within-pair between-pair scatter ratio (WPBPSR) distribution (P = 0.0269), though there was a shift in the xenografts toward more aggressive features including higher proliferation scores relative to the primary. Triple-negative breast tumors demonstrate superior ability to create xenografts compared to HR+ tumors, which may reflect higher proliferation or relatively stroma-independent growth of this subtype. Xenograft tumors’ gene expression faithfully resembles that of their parent tumors, yet also demonstrates a shift toward more aggressive molecular features.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 96,105,781 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

breast, cancer, article, google, scholar, pubmed, cas, tumors, xenografts, gene, xenograft, human, expression, primary, res, usa, laura, data, cell, university, research, john, molecular, models, privacy, cookies, petrillo, wolf, mice, subtype, stem, department, california, san, francisco, content, information, publish, search, parent, denise, ann, kapoun, park, intrinsic, aldh, access, treat, nature, springer,

Topics {✒️}

hasan korkaya pam50 gene set subtype-specific pathology month download article/chapter correlation-based techniques applied human tumour xenografts intrinsic subtype computational biology solutions breast cancer based tumor cell expression mouse intraductal author information authors breast cancer immunohistochemical reflect higher proliferation xenograft model full article pdf aggressive molecular features human breast tumors malignant breast tissues breast cancer metastasis human breast carcinomas human breast tumours parent breast tumors human cancers 70-gene prognosis signature large gene lists privacy choices/manage cookies gene expression breast tumors studied animal models utilized receptor cdk5/6 bmc cancer 10 max wicha check access instant access molecular heterogeneity breast cancer breast cancer intrinsic subtypes tumorigenic cell lines cultured cell lines stem cell marker european economic area ihc subtypes clustered poor clinical outcome germline brca2 mutation replicated microarray data conditions privacy policy triple-negative

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors
         description:Though xenografts are used extensively for drug development in breast cancer, how well xenografts reflect the breadth of primary breast tumor subtypes has not been well characterized. Moreover, few studies have compared the gene expression of xenograft tumors to the primary tumors from which they were derived. Here we investigate whether the ability of human breast tumors (n = 20) to create xenografts in immune-deficient mice is associated with breast cancer immunohistochemical (IHC) and intrinsic subtype. We also characterize how precisely the gene expression of xenografts reprises that of parent breast tumors, using hierarchical clustering and other correlation-based techniques applied to Agilent 44K gene expression data from 16 samples including four matched primary tumor-xenograft pairs. Of the breast tumors studied, 25 % (5/20) generated xenografts. Receptor and intrinsic subtype were significant predictors of xenograft success, with all (4/4) triple-negative (TN) tumors and no (0/12) HR+Her2− tumors forming xenografts (P = 0.0005). Tumor cell expression of ALDH1, a stem cell marker, trended toward successful engraftment (P = 0.14), though CDK5/6, a basal marker, did not. Though hierarchical clustering across the 500 most variable genes segregated human breast tumors from xenograft tumors, when clustering was performed over the PAM50 gene set the primary tumor-xenograft pairs clustered together, with all IHC subtypes clustered in distinct groups. Greater similarity between primary tumor-xenograft pairs relative to random pairings was confirmed by calculation of the within-pair between-pair scatter ratio (WPBPSR) distribution (P = 0.0269), though there was a shift in the xenografts toward more aggressive features including higher proliferation scores relative to the primary. Triple-negative breast tumors demonstrate superior ability to create xenografts compared to HR+ tumors, which may reflect higher proliferation or relatively stroma-independent growth of this subtype. Xenograft tumors’ gene expression faithfully resembles that of their parent tumors, yet also demonstrates a shift toward more aggressive molecular features.
         datePublished:2012-09-02T00:00:00Z
         dateModified:2012-09-02T00:00:00Z
         pageStart:913
         pageEnd:922
         sameAs:https://doi.org/10.1007/s10549-012-2226-y
         keywords:
            Mouse model
            Breast cancer
            Xenograft
            Receptor subtype
            Intrinsic subtype
            ALDH1
            CDK5/6
            PAM50
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig5_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:135
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Laura A. Petrillo
               affiliation:
                     name:University of California
                     address:
                        name:Department of Medicine, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Denise M. Wolf
               affiliation:
                     name:University of California
                     address:
                        name:Department of Laboratory Medicine, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Ann M. Kapoun
               affiliation:
                     name:OncoMed Pharmaceuticals, Inc.
                     address:
                        name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nicholas J. Wang
               affiliation:
                     name:Oregon Health & Science University
                     address:
                        name:Oregon Health & Science University, Portland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andrea Barczak
               affiliation:
                     name:University of California
                     address:
                        name:Functional Genomics Core, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuanyuan Xiao
               affiliation:
                     name:University of California
                     address:
                        name:Functional Genomics Core, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hasan Korkaya
               affiliation:
                     name:University of Michigan
                     address:
                        name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frederick Baehner
               affiliation:
                     name:University of California
                     address:
                        name:Department of Pathology, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John Lewicki
               affiliation:
                     name:OncoMed Pharmaceuticals, Inc.
                     address:
                        name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Max Wicha
               affiliation:
                     name:University of Michigan
                     address:
                        name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John W. Park
               affiliation:
                     name:University of California
                     address:
                        name:Department of Laboratory Medicine, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Paul T. Spellman
               affiliation:
                     name:Oregon Health & Science University
                     address:
                        name:Oregon Health & Science University, Portland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joe W. Gray
               affiliation:
                     name:Oregon Health & Science University
                     address:
                        name:Oregon Health & Science University, Portland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laura van’t Veer
               affiliation:
                     name:University of California
                     address:
                        name:Department of Laboratory Medicine, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laura J. Esserman
               affiliation:
                     name:University of California
                     address:
                        name:Department of Surgery, University of California, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors
      description:Though xenografts are used extensively for drug development in breast cancer, how well xenografts reflect the breadth of primary breast tumor subtypes has not been well characterized. Moreover, few studies have compared the gene expression of xenograft tumors to the primary tumors from which they were derived. Here we investigate whether the ability of human breast tumors (n = 20) to create xenografts in immune-deficient mice is associated with breast cancer immunohistochemical (IHC) and intrinsic subtype. We also characterize how precisely the gene expression of xenografts reprises that of parent breast tumors, using hierarchical clustering and other correlation-based techniques applied to Agilent 44K gene expression data from 16 samples including four matched primary tumor-xenograft pairs. Of the breast tumors studied, 25 % (5/20) generated xenografts. Receptor and intrinsic subtype were significant predictors of xenograft success, with all (4/4) triple-negative (TN) tumors and no (0/12) HR+Her2− tumors forming xenografts (P = 0.0005). Tumor cell expression of ALDH1, a stem cell marker, trended toward successful engraftment (P = 0.14), though CDK5/6, a basal marker, did not. Though hierarchical clustering across the 500 most variable genes segregated human breast tumors from xenograft tumors, when clustering was performed over the PAM50 gene set the primary tumor-xenograft pairs clustered together, with all IHC subtypes clustered in distinct groups. Greater similarity between primary tumor-xenograft pairs relative to random pairings was confirmed by calculation of the within-pair between-pair scatter ratio (WPBPSR) distribution (P = 0.0269), though there was a shift in the xenografts toward more aggressive features including higher proliferation scores relative to the primary. Triple-negative breast tumors demonstrate superior ability to create xenografts compared to HR+ tumors, which may reflect higher proliferation or relatively stroma-independent growth of this subtype. Xenograft tumors’ gene expression faithfully resembles that of their parent tumors, yet also demonstrates a shift toward more aggressive molecular features.
      datePublished:2012-09-02T00:00:00Z
      dateModified:2012-09-02T00:00:00Z
      pageStart:913
      pageEnd:922
      sameAs:https://doi.org/10.1007/s10549-012-2226-y
      keywords:
         Mouse model
         Breast cancer
         Xenograft
         Receptor subtype
         Intrinsic subtype
         ALDH1
         CDK5/6
         PAM50
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-012-2226-y/MediaObjects/10549_2012_2226_Fig5_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:135
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Laura A. Petrillo
            affiliation:
                  name:University of California
                  address:
                     name:Department of Medicine, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Denise M. Wolf
            affiliation:
                  name:University of California
                  address:
                     name:Department of Laboratory Medicine, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Ann M. Kapoun
            affiliation:
                  name:OncoMed Pharmaceuticals, Inc.
                  address:
                     name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nicholas J. Wang
            affiliation:
                  name:Oregon Health & Science University
                  address:
                     name:Oregon Health & Science University, Portland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andrea Barczak
            affiliation:
                  name:University of California
                  address:
                     name:Functional Genomics Core, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuanyuan Xiao
            affiliation:
                  name:University of California
                  address:
                     name:Functional Genomics Core, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hasan Korkaya
            affiliation:
                  name:University of Michigan
                  address:
                     name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frederick Baehner
            affiliation:
                  name:University of California
                  address:
                     name:Department of Pathology, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John Lewicki
            affiliation:
                  name:OncoMed Pharmaceuticals, Inc.
                  address:
                     name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Max Wicha
            affiliation:
                  name:University of Michigan
                  address:
                     name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John W. Park
            affiliation:
                  name:University of California
                  address:
                     name:Department of Laboratory Medicine, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Paul T. Spellman
            affiliation:
                  name:Oregon Health & Science University
                  address:
                     name:Oregon Health & Science University, Portland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joe W. Gray
            affiliation:
                  name:Oregon Health & Science University
                  address:
                     name:Oregon Health & Science University, Portland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laura van’t Veer
            affiliation:
                  name:University of California
                  address:
                     name:Department of Laboratory Medicine, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laura J. Esserman
            affiliation:
                  name:University of California
                  address:
                     name:Department of Surgery, University of California, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:135
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of California
      address:
         name:Department of Medicine, University of California, San Francisco, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Laboratory Medicine, University of California, San Francisco, USA
         type:PostalAddress
      name:OncoMed Pharmaceuticals, Inc.
      address:
         name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
         type:PostalAddress
      name:Oregon Health & Science University
      address:
         name:Oregon Health & Science University, Portland, USA
         type:PostalAddress
      name:University of California
      address:
         name:Functional Genomics Core, University of California, San Francisco, USA
         type:PostalAddress
      name:University of California
      address:
         name:Functional Genomics Core, University of California, San Francisco, USA
         type:PostalAddress
      name:University of Michigan
      address:
         name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Pathology, University of California, San Francisco, USA
         type:PostalAddress
      name:OncoMed Pharmaceuticals, Inc.
      address:
         name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
         type:PostalAddress
      name:University of Michigan
      address:
         name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Laboratory Medicine, University of California, San Francisco, USA
         type:PostalAddress
      name:Oregon Health & Science University
      address:
         name:Oregon Health & Science University, Portland, USA
         type:PostalAddress
      name:Oregon Health & Science University
      address:
         name:Oregon Health & Science University, Portland, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Laboratory Medicine, University of California, San Francisco, USA
         type:PostalAddress
      name:University of California
      address:
         name:Department of Surgery, University of California, San Francisco, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Laura A. Petrillo
      affiliation:
            name:University of California
            address:
               name:Department of Medicine, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Denise M. Wolf
      affiliation:
            name:University of California
            address:
               name:Department of Laboratory Medicine, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Ann M. Kapoun
      affiliation:
            name:OncoMed Pharmaceuticals, Inc.
            address:
               name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
               type:PostalAddress
            type:Organization
      name:Nicholas J. Wang
      affiliation:
            name:Oregon Health & Science University
            address:
               name:Oregon Health & Science University, Portland, USA
               type:PostalAddress
            type:Organization
      name:Andrea Barczak
      affiliation:
            name:University of California
            address:
               name:Functional Genomics Core, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Yuanyuan Xiao
      affiliation:
            name:University of California
            address:
               name:Functional Genomics Core, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Hasan Korkaya
      affiliation:
            name:University of Michigan
            address:
               name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
               type:PostalAddress
            type:Organization
      name:Frederick Baehner
      affiliation:
            name:University of California
            address:
               name:Department of Pathology, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:John Lewicki
      affiliation:
            name:OncoMed Pharmaceuticals, Inc.
            address:
               name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
               type:PostalAddress
            type:Organization
      name:Max Wicha
      affiliation:
            name:University of Michigan
            address:
               name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
               type:PostalAddress
            type:Organization
      name:John W. Park
      affiliation:
            name:University of California
            address:
               name:Department of Laboratory Medicine, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Paul T. Spellman
      affiliation:
            name:Oregon Health & Science University
            address:
               name:Oregon Health & Science University, Portland, USA
               type:PostalAddress
            type:Organization
      name:Joe W. Gray
      affiliation:
            name:Oregon Health & Science University
            address:
               name:Oregon Health & Science University, Portland, USA
               type:PostalAddress
            type:Organization
      name:Laura van’t Veer
      affiliation:
            name:University of California
            address:
               name:Department of Laboratory Medicine, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Laura J. Esserman
      affiliation:
            name:University of California
            address:
               name:Department of Surgery, University of California, San Francisco, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medicine, University of California, San Francisco, USA
      name:Department of Laboratory Medicine, University of California, San Francisco, USA
      name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
      name:Oregon Health & Science University, Portland, USA
      name:Functional Genomics Core, University of California, San Francisco, USA
      name:Functional Genomics Core, University of California, San Francisco, USA
      name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
      name:Department of Pathology, University of California, San Francisco, USA
      name:OncoMed Pharmaceuticals, Inc., Redwood City, USA
      name:Department of Internal Medicine, University of Michigan, Ann Arbor, USA
      name:Department of Laboratory Medicine, University of California, San Francisco, USA
      name:Oregon Health & Science University, Portland, USA
      name:Oregon Health & Science University, Portland, USA
      name:Department of Laboratory Medicine, University of California, San Francisco, USA
      name:Department of Surgery, University of California, San Francisco, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(202)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
4.84s.